Neil Gallagher, MD, PHD

Dr. Gallagher has over 20 years of experience at pharmaceutical and biopharmaceutical organizations leading drug development programs across several therapeutic areas, including oncology. Currently he serves as the President, Head of Research and Development at Syndax Pharmaceuticals. Prior to that, he held clinical development roles at AbbVie, including serving as the Chief Medical Officer, Vice President, Head of Development. Dr. Gallagher also held development positions at Amgen, spent a decade at Novartis Oncology, and earlier in his career held roles at AstraZeneca and Astex Therapeutics. He also serves on the Board of Directors of Zymeworks and as an advisor to the Board of Nouscom.

Dr. Gallagher completed his fellowship in gynecological oncology at the Institute for Cancer Studies, University of Birmingham, UK, and received his medical degree from Trinity College, Dublin.